Assessing The Effects of Dtc Advertising on The Pharmaceutical Market
Bibliographic record
Abstract
The landscape of pharmaceutical marketing has evolved significantly with the emergence of Direct-to-Consumer (DTC) advertising, fundamentally reshaping the relationship between pharmaceutical companies, healthcare providers, and patients. This review article explores the multifaceted impact of DTC advertising on pharmaceutical sales and the broader healthcare ecosystem. Initially, pharmaceutical marketing primarily targeted healthcare professionals through detailing, but regulatory changes in the 1990s, particularly in the U.S., enabled direct engagement with consumers via mass media and digital platforms.The review provides a detailed examination of DTC advertising's regulatory framework, comparing the permissive environment of the U.S. with the stricter regulations in the European Union, Canada, and Australia. A key focus is the analysis of how DTC campaigns affect pharmaceutical sales, highlighting the sharp increases in drug sales, especially for blockbuster medications, following the launch of major advertising campaigns. Quantitative analyses and case studies reveal that drugs such as Lipitor and Viagra experienced significant sales boosts due to DTC strategies.The article also investigates the impact of DTC advertising on consumer behavior, noting how advertising shapes consumer perceptions, increases awareness of health conditions, and drives demand for specific medications. Additionally, the influence of DTC ads on the doctor-patient relationship is discussed, showing how patients’ requests for advertised drugs may affect prescribing patterns and clinical decision-making.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.011 | 0.038 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.001 |
| Bibliometrics | 0.002 | 0.003 |
| Science and technology studies | 0.001 | 0.001 |
| Scholarly communication | 0.004 | 0.003 |
| Open science | 0.000 | 0.001 |
| Research integrity | 0.001 | 0.001 |
| Insufficient payload (model declined to judge) | 0.006 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".